A Phase 2 Study of Alisertib In Patients With Extensive Stage Small Cell Lung Cancer

Phase II Clinical Trial

A PHASE 2 STUDY OF ALISERTIB IN PATIENTS WITH EXTENSIVE SMALL CELL LUNG CANCER (PUMA-ALI-4201)

Indication: Lung Cancer, Lung Cancer, Lung Cancer, Lung Cancer
Trial Number: 06095505
Trial Status: OPEN

Learn more about this clinical trial.

Participating Locations